| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.08B | 13.06B | 40.45B | 40.17B | 7.66B |
| Gross Profit | 3.91B | 5.30B | 34.35B | 34.15B | 4.69B |
| EBITDA | 4.40B | 5.44B | 37.66B | 41.46B | 4.59B |
| Net Income | 450.65M | -7.90B | 7.28B | 23.94B | 3.65B |
Balance Sheet | |||||
| Total Assets | 73.10B | 69.56B | 74.97B | 72.56B | 45.80B |
| Cash, Cash Equivalents and Short-Term Investments | 5.71B | 6.42B | 9.35B | 12.46B | 1.99B |
| Total Debt | 15.49B | 14.92B | 11.76B | 8.71B | 21.81B |
| Total Liabilities | 21.12B | 19.50B | 19.01B | 17.80B | 26.01B |
| Stockholders Equity | 42.38B | 42.77B | 51.52B | 50.16B | 14.36B |
Cash Flow | |||||
| Free Cash Flow | -583.56M | 1.03B | 18.25B | 18.58B | 1.23B |
| Operating Cash Flow | 2.93B | 5.55B | 22.69B | 20.30B | 2.23B |
| Investing Cash Flow | -4.41B | -5.88B | -2.02B | 744.01M | -65.19M |
| Financing Cash Flow | -417.37M | -3.24B | -23.44B | -10.57B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$30.26B | 2.54 | 23.38% | 1.89% | 60.77% | 100.45% | |
72 Outperform | HK$60.05B | 22.66 | 32.65% | 1.32% | 31.24% | 58.16% | |
64 Neutral | HK$414.51B | 18.57 | 26.48% | 1.45% | -2.42% | 38.68% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | HK$103.75B | 166.81 | -4.82% | 2.80% | -39.59% | 69.00% |